EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Cell reprogramming for oligodendrocytes: A review of protocols and their applications to disease modeling and cell‐based remyelination therapies

Amy McCaughey-Chapman, Bronwen Connor

Journal of Neuroscience Research · 2023

DOI: 10.1002/jnr.25173 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Neuroscience Research, 2023. Verfasst von Amy McCaughey-Chapman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Clinical Pharmacology, Centre for Brain Research, School of Medical Science, Faculty of Medical and Health Sciences, U…. Hauptthemen laut MEDLINE: Remyelination, Demyelinating Diseases, Spinal Cord Injuries, Multiple Sclerosis. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oligodendrocytes are a type of glial cells that produce a lipid‐rich membrane called myelin. Myelin assembles into a sheath and lines neuronal axons in the brain and spinal cord to insulate them. This not only increases the speed and efficiency of nerve signal transduction but also protects the axons from damage and degradation, which could trigger neuronal cell death. Demyelination, which is caused by a loss of myelin and oligodendrocytes, is a prominent feature of many neurological conditions, including Multiple sclerosis (MS), spinal cord injuries (SCI), and leukodystrophies. Demyelination is followed by a time of remyelination mediated by the recruitment of endogenous oligodendrocyte precursor cells, their migration to the injury site, and differentiation into myelin‐producing oligodendrocytes. Unfortunately, endogenous remyelination is not sufficient to overcome demyelination, which explains why there are to date no regenerative‐based treatments for MS, SCI, or leukodystrophies. To better understand the role of oligodendrocytes and develop cell‐based remyelination therapies, human oligodendrocytes have been derived from somatic cells using cell reprogramming. This review will detail the different cell reprogramming methods that have been developed to generate human oligodendrocytes and their applications to disease modeling and cell‐based remyelination therapies. Recent developments in the field have seen the derivation of brain organoids from pluripotent stem cells, and protocols have been devised to incorporate oligodendrocytes within the organoids, which will also be reviewed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RemyelinationDemyelinating DiseasesSpinal Cord InjuriesMultiple SclerosisHumansCellular ReprogrammingOligodendrogliaMyelin SheathCell Differentiation

Stichwörter der Autor:innen

cell-based remyelination therapydemyelinationdisease modelinginduced pluripotent stem cellsmultiple sclerosisoligodendrocyteoligodendrocyte precursor cellsorganoidsreprogrammingspinal cord injury

Autor:innen und Institutionen

  • Department of Pharmacology and Clinical Pharmacology, Centre for Brain Research, School of Medical Science, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.

Zitieren

APA

McCaughey-Chapman, A., & Connor, B. (2023). Cell reprogramming for oligodendrocytes: A review of protocols and their applications to disease modeling and cell‐based remyelination therapies. Journal of Neuroscience Research. https://doi.org/10.1002/jnr.25173

Vancouver

McCaughey-Chapman A, Connor B. Cell reprogramming for oligodendrocytes: A review of protocols and their applications to disease modeling and cell‐based remyelination therapies. Journal of Neuroscience Research. 2023. doi:10.1002/jnr.25173

BibTeX
@article{McCaugheyChapman2023,
  author = {McCaughey-Chapman, Amy and Connor, Bronwen},
  title = {Cell reprogramming for oligodendrocytes: A review of protocols and their applications to disease modeling and cell‐based remyelination therapies},
  journal = {Journal of Neuroscience Research},
  year = {2023},
  doi = {10.1002/jnr.25173}
}
Kostenlos starten →